CIPO trademark

ACARIZAX

RegisteredCIPOWord markClass 5Class 41Class 42Class 44

"ACARIZAX" is a word mark owned by Alk-Abelló A/S, filed at the CIPO on October 27, 2016. It is registered and covers classes 5, 41, 42 and 44.

View Alk-Abelló A/S portfolioGet this data via the API
Official CIPO record
ACARIZAX
Word mark as filed with the CIPO
Status
Registered
Since May 3, 2018
Filed
October 27, 2016
Registered
May 3, 2018
Expires
May 3, 2033
Application no.
1807677
Registration no.
TMA995868
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
4 classes
Ownership

Who owns ACARIZAX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alk-Abelló A/S

Denmark

191 trademarks in the portfolioView company

Representative

Deeth Williams Wall LLP

Deeth Williams Wall LLP

Goods and services

What the mark covers

The products and services ACARIZAX is filed for, grouped by Nice class.

  • Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes in relation to allergies, asthma, allergic rhinitis, rhinoconjunctivitis, allergic asthma and respiratory allergic diseases, and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases.; Diagnostic preparations for medical purposes, diagnostic reagents and diagnostic testing materials for diagnosing, preventing and treating allergies, asthma, rhinitis, rhinoconjunctivitis and respiratory diseases.; Pharmaceutical preparations in the form of injectable pharmaceuticals, namely, injectable adrenaline for treatment of anaphylactic reactions and injectable preparations for treatment and prevention of allergies, asthma, rhinitis, rhinoconjunctivitis and respiratory diseases.

  • Medical and pharmacological research services; medical laboratory services, clinical trials.; Medical consulting services, namely, providing counselling and medical information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions; providing patient support relating to immunotherapy and the diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet; providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.

  • Medical and pharmacological research services; medical laboratory services, clinical trials.; Medical consulting services, namely, providing counselling and medical information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions; providing patient support relating to immunotherapy and the diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet; providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.

  • Medical and pharmacological research services; medical laboratory services, clinical trials.; Medical consulting services, namely, providing counselling and medical information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions; providing patient support relating to immunotherapy and the diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet; providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Allowance Notice Sent
  3. Allowed
  4. Advertised; Vol.64 Issue 3293
  5. Approved; APPROVED BY PROGRAM EX200M1
  6. Approval Notice Sent
  7. Examiner's First Report
  8. Search Recorded
  9. Amendment to Application; Section 41(1)(a) - Owner Information / Voir Preuve au dossier/See evidence on File No. 1807677
  10. Formalized

2 earlier steps on the official record.

FAQ

About ACARIZAX

Who owns the trademark "ACARIZAX"?

The CIPO trademark "ACARIZAX" (application 1807677) is owned by Alk-Abelló A/S.

What is the status of "ACARIZAX"?

Its status at the CIPO is: registered.

When was "ACARIZAX" registered?

It was registered on May 3, 2018 and is due to expire on May 3, 2033.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ACARIZAX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb5e-74b5-768d-88f1-96732155889c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb5e-74b5-768d-88f1-96732155889c",
  "object": "trademark",
  "mark_text": "ACARIZAX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "1807677",
  "filing_date": "2016-10-27",
  "nice_classes": [
    5,
    41,
    42,
    44
  ],
  "owners": [
    {
      "name": "ALK-ABELLÓ A/S",
      "entity_id": "ent_019eb6f7-d7a6-7420-874f-900c24eb0227"
    }
  ]
}